The cannabis derivative cannabidiol in the treatment of schizophrenia: results of the first placebo-controlled clinical trial
Dr Phil Robson, Honorary Senior Research Fellow, University Department of Psychiatry, University of Oxford
Psychiatry Seminar
Tuesday, 03 November 2015, 9.31am to 10.30am
Seminar Room, University Department of Psychiatry, Warneford Hospital